Constitutive asymmetric dimerization drives oncogenic activation of epidermal growth factor receptor carboxyl-terminal deletion mutants

Angela Kyung-Joo Park(Samsung Medical Center), Jeonghee Cho(Dankook University)

Oncotarget

March 12, 2015

10.18632/oncotarget.3559

Cited by 16

Related Papers

Whole Transcriptome Analysis Identifies TNS4 as a Key Effector of Cetuximab and a Regulator of the Oncogenic Activity of KRAS Mutant Colorectal Cancer Cell Lines

|Cells|2019|22

Autophosphorylation of the carboxyl‐terminal domain is not required for oncogenic transformation by lung‐cancer derived <scp>EGFR</scp> mutants

|International Journal of Cancer|2018|9

Functional loss of <scp>ERBB</scp> receptor feedback inhibitor 1 ( <scp>MIG6</scp> ) promotes glioblastoma tumorigenesis by aberrant activation of epidermal growth factor receptor ( <scp>EGFR</scp> )

|Molecular Oncology|2024|1